The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.
Lemmens, S; Van Craenendonck, T; Van Eijgen, J; De Groef, L; Bruffaerts, R; de Jesus, DA; Charle, W; Jayapala, M; Sunaric-Megevand, G; Standaert, A; Theunis, J; Van Keer, K; Vandenbulcke, M; Moons, L; Vandenberghe, R; De Boever, P; Stalmans, I
